T-Rex 2X Long MSTR Daily Target ETF vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? T-Rex 2X Long MSTR Daily Target ETF trades at $39.78 (market cap $809.00M), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.32 (market cap $2.27B). The key difference: SELLAS Life Sciences Group Inc. Common Stock is far larger — about 2.8× T-Rex 2X Long MSTR Daily Target ETF's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, T-Rex 2X Long MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals.
| MSTU | SLS | |
|---|---|---|
Market Cap | $809.00M | $2.27B |
Volume | 4,577,465 | 4,179,659 |
Sector | Leveraged / Inverse | Health |
52-Week High | $451.00 | $15.46 |
52-Week Low | $14.60 | $1.39 |
Typical Hold Time | 18 Days | — |
Enterprise Value | — | $2.14B |
Signals from Pluang's Aura AI — not financial advice
MSTU is experiencing significant downward pressure with the stock declining 13.68% to $39.45 amid bearish technical signals. The reverse stock split effective August 24, 2026, and upcoming dividend payment suggest corporate restructuring efforts. Technical indicators show mixed signals with moving averages bearish but oscillators neutral, while support levels cluster around $36-38.
The outlook remains challenging with technical weakness and limited fundamental visibility. Investment opportunity exists for contrarian investors betting on stabilization, though risks include continued volatility from leveraged ETF mechanics and dependence on underlying stock performance. The absence of key financial ratios warrants caution for fundamental investors.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →